Vismodegib Patent Expiration
Vismodegib is Used for treating basal cell carcinoma and cancer in mammals. It was first introduced by Genentech Inc
Vismodegib Patents
Given below is the list of patents protecting Vismodegib, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Erivedge | US9278961 | Pyridyl inhibitors of hedgehog signalling | Dec 15, 2028 | Genentech |
| Erivedge | US7888364 | Pyridyl inhibitors of hedgehog signalling | Nov 11, 2028 | Genentech |
| Erivedge | US9790183 | Pyridyl inhibitors of hedgehog signalling | Sep 02, 2025 | Genentech |
Vismodegib's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List